Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. IDEXX Laboratories, Inc.
  6. News
  7. Summary
    IDXX   US45168D1046

IDEXX LABORATORIES, INC.

(IDXX)
  Report
Delayed Nasdaq  -  04:00 2022-08-08 pm EDT
407.00 USD   -0.19%
08/08Piper Sandler Adjusts Price Target on IDEXX Laboratories to $500 From $420, Reiterates Overweight Rating
MT
08/05Barclays Adjusts Price Target on IDEXX Laboratories to $582 From $700, Reiterates Overweight Rating
MT
08/04Morgan Stanley Lowers IDEXX Laboratories Price Target to $573 From $603, Maintains Overweight Rating
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

IDEXX Laboratories : Earnings, Revenue Rise in Q4, Unveils 2021 Outlook

02/02/2021 | 07:41am EDT
share with twitter
share with LinkedIn
share with facebook


© MT Newswires 2021
All news about IDEXX LABORATORIES, INC.
08/08Piper Sandler Adjusts Price Target on IDEXX Laboratories to $500 From $420, Reiterates ..
MT
08/05Barclays Adjusts Price Target on IDEXX Laboratories to $582 From $700, Reiterates Overw..
MT
08/04Morgan Stanley Lowers IDEXX Laboratories Price Target to $573 From $603, Maintains Over..
MT
08/03Atlantic Equities Adjusts Price Target on IDEXX Laboratories to $490 From $500, Reitera..
MT
08/02IDEXX LABORATORIES INC /DE Management's Discussion and Analysis of Financial Condition..
AQ
08/02WALL STREET STOCK EXCHANGE : Pelosi’s expected Taiwan visit spooks markets
MS
08/02SECTOR UPDATE : Health Care Stocks Lean Lower Pre-Bell Tuesday
MT
08/02TRANSCRIPT : IDEXX Laboratories, Inc., Q2 2022 Earnings Call, Aug 02, 2022
CI
08/02IDEXX Laboratories Q2 Profit Declines While Revenue Rises; Lowers Full-Year 2022 Outloo..
MT
08/02IDEXX LABORATORIES : Announces Second Quarter Results - Form 8-K
PU
More news
Analyst Recommendations on IDEXX LABORATORIES, INC.
More recommendations
Financials (USD)
Sales 2022 3 382 M - -
Net income 2022 687 M - -
Net Debt 2022 1 126 M - -
P/E ratio 2022 50,3x
Yield 2022 -
Capitalization 34 191 M 34 191 M -
EV / Sales 2022 10,4x
EV / Sales 2023 9,55x
Nbr of Employees 10 350
Free-Float 77,1%
Chart IDEXX LABORATORIES, INC.
Duration : Period :
IDEXX Laboratories, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends IDEXX LABORATORIES, INC.
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 12
Last Close Price 407,00 $
Average target price 477,00 $
Spread / Average Target 17,2%
EPS Revisions
Managers and Directors
Jonathan J. Mazelsky President, Chief Executive Officer & Director
Brian Patrick McKeon Chief Financial Officer, Treasurer & Executive VP
Lawrence D. Kingsley Non-Executive Chairman
Ken Grady Chief Information Officer & Senior VP
Murthy Yerramilli Senior Vice President-Research & Development
Sector and Competitors
1st jan.Capi. (M$)
IDEXX LABORATORIES, INC.-38.07%34 191
ABBOTT LABORATORIES-22.37%190 883
MEDTRONIC PLC-9.83%124 341
STRYKER CORPORATION-18.73%82 217
BECTON, DICKINSON AND COMPANY4.15%73 001
HOYA CORPORATION-15.34%38 786